VPS72 controls Treg cell stability and adaptation to tumor microenvironment
VPS72 controls Treg cell stability and adaptation to tumor microenvironment
批准号:
10754017
负责人:
Deyu Fang
金额:
$65.81万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-19 至 2028-08-31
关键词:
ATAC-seqAgeAmino AcidsAutoimmune DiseasesBiological ProcessBiologyCell LineageCell MaintenanceCell SurvivalCell physiologyCellsCellular biologyChromatinChromatin StructureDevelopmentEpigenetic ProcessEventFOXP3 geneGene DeletionGenetic TranscriptionGlucoseHistone H2AHistonesHomeostasisHomologous GeneHypoxiaImmuneImmunosuppressionImmunotherapyIn VitroIndividualInfiltrationInterruptionInterventionKnock-outKnockout MiceMalignant NeoplasmsMediatingModelingMolecularMolecular ChaperonesMusOncogenesOrganPathway interactionsPeripheralPhenocopyPlayProceduresProtein IsoformsProteinsRegulationRegulatory T-LymphocyteResearchRoleSignal PathwayStressT-Cell DevelopmentTestingThymus GlandTransplantationTumor EscapeTumor ImmunityTumor PromotionVacuolar Protein SortingVariantWorkanti-PD-1antitumor effectcancer immunotherapycancer therapychromatin remodelingcytokineepigenetic regulationexperiencefitnessforkhead proteinimmune checkpoint blockadeimmune functionimmunoregulationimprovedin vivoinsightmelanomamitochondrial metabolismmouse modelmultiple omicsneoplastic celloverexpressionsingle-cell RNA sequencingsuccesssynergismtranscriptome sequencingtumortumor immunologytumor microenvironment
中文摘要
摘要
众所周知,肿瘤微环境内的免疫抑制生态位
(TME)与肿瘤免疫逃逸和进展有关,其中调节性T细胞(Tregs)
发挥重要作用。尽管在鉴定转录和转录因子方面取得了一些进展
TME中Treg功能调控的表观遗传事件,我们的
了解详细的表观遗传网络介导Treg的生存、扩张和
TME诱导的免疫抑制功能增强。空泡蛋白分类72同系物
(VPS72),一种组蛋白伴侣蛋白,识别组蛋白H2A.Z并将其交换为标准组蛋白
H_2A,已在体外研究中表明,它调节基因转录,特别是与
线粒体通过染色质重塑代谢,尽管体内的生物学功能
VPS72的致病原因尚不清楚。我们的初步研究显示,该基因的高表达和阳性
TME内Tregs中VPS72和Foxp3的相关性有趣的是,我们的Treg专属
VPS72 KO和H2 A.Z KO小鼠模型显示胸腺Treg发育正常,但
严重中断了外围设备Treg的维护和功能。这些结果导致我们的
核心假设VPS72是一种关键的表观遗传因子,可由TME因子诱导
并通过TME中Treg的H_2A.Z染色质重塑增强Treg的稳定性和功能。
在拟议的研究中,我们使用了Treg特异的结构性和诱导性基因缺失
建立小鼠模型以确定VPS72和H2 AZ在外周Treg细胞维持中的作用,
在癌症中的稳定性和功能。结合使用scRNA-seq、scATAC-seq和Cut&Run-
SEQ多组分析,我们将勾勒出表观遗传策略和详细的分子
VPS72调控Treg动态平衡和功能的机制和信号通路。
在移植瘤和自发性黑色素瘤模型中,我们将评估其抗肿瘤作用
VPS72和H_2AZ抑制。此外,TME影响因素及其相关的分子机制
在上调Tme中Tregs的VPS72表达的同时,也将对其进行研究。调查结果:
拟议的研究不仅将增进我们对Treg生物学的了解,还将促进
开发更有效的基于Treg的癌症治疗干预策略。
英文摘要
Abstract
It became well known that the immune suppressive niche inside the tumor microenvironment
(TME) accounts for tumor immune escape and progression, in which the regulatory T cells (Tregs)
play an important role. Although some progress has been made in identifying transcriptional and
epigenetic events in Treg functional regulation in TME, a fundamental gap remains in our
understanding the detailed epigenetic networks mediating Treg survival, expansion and
enhanced immune suppressive function induced by TME. Vacuolar protein sorting 72 homolog
(VPS72), a histone chaperone that recognizes and exchanges histone H2A.Z for standard histone
H2A, has been shown in in vitro studies that regulate gene transcriptions especially related in
mitochondrial metabolism through chromatin remodeling, although the in vivo biological function
of VPS72 remains unknown. Our preliminary studies revealed the higher expression and positive
correlation between VPS72 and Foxp3 in the Tregs inside the TME. Intriguingly, our Treg-specific
VPS72 KO and H2A.Z KO mouse models showed normal thymic Treg development, but
dramatically interrupted peripheral Treg maintenance and function. These results led to our
central hypothesis that VPS72 is a critical epigenetic factor that can be induced by TME factors
and enhance Treg stability and function through H2A.Z chromatin remodeling of Treg in the TME.
In the proposed studies, we are using Treg-specific constitutive and inducible gene deletion
mouse models to determine the role of VPS72 and H2AZ in peripheral Treg cell maintenance,
stability and function in the cancer. Using combined scRNA-seq, scATAC-seq, and CUT & RUN-
seq multi-omic analysis, we will delineate the epigenetic strategies and detailed molecular
mechanisms and signaling pathways VPS72 used in controlling Treg homeostasis and function.
In transplant and spontaneous melanoma tumor models, we will evaluate the anti-tumor effects
of VPS72 and H2AZ suppression. Furthermore, TME factors and related molecular mechanisms
in upregulating VPS72 expression of Tregs in TME will be also investigated. Results from the
proposed study will not only enhance our understanding of Treg biology but will also facilitate the
development of more efficient Treg-based intervention strategies for cancer treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical analysis and therapeutic development of exosomal ACE2
-
批准号:10531071
-
项目类别:
-
资助金额:$77.94万
-
财政年份:2022
-
负责人:Deyu Fang
-
依托单位:
Clinical analysis and therapeutic development of exosomal ACE2
-
批准号:10666589
-
项目类别:
-
资助金额:$74.85万
-
财政年份:2022
-
负责人:Deyu Fang
-
依托单位:
A deubiquitination module controls Treg adaptation to tumor microenvironment
-
批准号:10152123
-
项目类别:
-
资助金额:$56.16万
-
财政年份:2021
-
负责人:Deyu Fang
-
依托单位:
A deubiquitination module controls Treg adaptation to tumor microenvironment
-
批准号:10545001
-
项目类别:
-
资助金额:$55.21万
-
财政年份:2021
-
负责人:Deyu Fang
-
依托单位:
Regulation of Rhythmic m6A RNA Modification by ER‐associated Degradation
-
批准号:10297978
-
项目类别:
-
资助金额:$57.48万
-
财政年份:2021
-
负责人:Deyu Fang
-
依托单位:
Regulation of Rhythmic m6A RNA Modification by ER‐associated Degradation
-
批准号:10615181
-
项目类别:
-
资助金额:$54.91万
-
财政年份:2021
-
负责人:Deyu Fang
-
依托单位:
A deubiquitination module controls Treg adaptation to tumor microenvironment
-
批准号:10320965
-
项目类别:
-
资助金额:$55.35万
-
财政年份:2021
-
负责人:Deyu Fang
-
依托单位:
Regulation of Rhythmic m6A RNA Modification by ER‐associated Degradation
-
批准号:10454294
-
项目类别:
-
资助金额:$55.86万
-
财政年份:2021
-
负责人:Deyu Fang
-
依托单位:
Targeting a Treg deubiquitinase in antitumor immune therapy
-
批准号:10429984
-
项目类别:
-
资助金额:$34.51万
-
财政年份:2018
-
负责人:Deyu Fang
-
依托单位:
Novel Role of Hepatic SEL1L-HRD1 ERAD in FGF21 Gene Transcription
-
批准号:9792378
-
项目类别:
-
资助金额:$53.04万
-
财政年份:2018
-
负责人:Deyu Fang
-
依托单位:
Novel Role of Hepatic SEL1L-HRD1 ERAD in Bile Acid Metabolism
-
批准号:10584953
-
项目类别:
-
资助金额:$70.04万
-
财政年份:2018
-
负责人:Deyu Fang
-
依托单位:
Targeting a Treg deubiquitinase in antitumor immune therapy
-
批准号:10197845
-
项目类别:
-
资助金额:$35.22万
-
财政年份:2018
-
负责人:Deyu Fang
-
依托单位:
Simultaneous Targeting of IRE1a in B Cells and Macrophages for Lupus Therapy
-
批准号:8751549
-
项目类别:
-
资助金额:$35.07万
-
财政年份:2014
-
负责人:Deyu Fang
-
依托单位:
The roles of Synoviolin in immune tolerance and autoimmunity
-
批准号:8890108
-
项目类别:
-
资助金额:$37.95万
-
财政年份:2014
-
负责人:Deyu Fang
-
依托单位:
Simultaneous Targeting of IRE1a in B Cells and Macrophages for Lupus Therapy
-
批准号:9293889
-
项目类别:
-
资助金额:$33.88万
-
财政年份:2014
-
负责人:Deyu Fang
-
依托单位:
The roles of Synoviolin in immune tolerance and autoimmunity
-
批准号:8756545
-
项目类别:
-
资助金额:$37.95万
-
财政年份:2014
-
负责人:Deyu Fang
-
依托单位:
The roles of Synoviolin in immune tolerance and autoimmunity
-
批准号:9089984
-
项目类别:
-
资助金额:$37.95万
-
财政年份:2014
-
负责人:Deyu Fang
-
依托单位:
A novel target for type 1 diabetes
-
批准号:8012354
-
项目类别:
-
资助金额:$9.77万
-
财政年份:2010
-
负责人:Deyu Fang
-
依托单位:
The roles of Sirt1, a deacetylase, in immune tolerance and autoimmunity
-
批准号:8147894
-
项目类别:
-
资助金额:$18.0万
-
财政年份:2010
-
负责人:Deyu Fang
-
依托单位:
A novel target for type 1 diabetes
-
批准号:8139429
-
项目类别:
-
资助金额:$0.23万
-
财政年份:2008
-
负责人:Deyu Fang
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: